Abstract:Recent studies reported that circulating microRNAs (miRNAs) can target different metalloproteases (MMPs) involved in matrix remodeling and plaque vulnerability. Consequently, they might have a role in the diagnosis and prognosis of coronary artery disease. To quantify circulating miRNAs (miRNA126, miRNA146, and miRNA21) suggested to have possible cardiovascular implications, as well as levels of MMP-1 and MMP-9, and to determine their association with left ventricular (LV) function and with arterial function, in patients with either ST-segment elevation acute myocardial infarction (STEMI) or stable ischemic heart disease (SIHD). A total of 90 patients with coronary artery disease (61% men, 58 ± 12 years), including 60 patients with STEMI and 30 patients with SIHD, were assessed within 24 h of admission, by measuring serum microRNAs, and serum MMP-1 and MMP-9. LV function was assessed by measuring ejection fraction (EF) by 2D and 3D echocardiography, and global longitudinal strain (GLS) by speckle tracking. Arterial function was assessed by echo tracking, CAVI, and peripheral Doppler. Circulating levels of miRNA146, miRNA21, and MMP1 were significantly increased in patients with STEMI vs. SIHD (p = 0.0001, p = 0.0001, p = 0.04, respectively). MiRNA126 negatively correlated with LVEF (r = −0.33, p = 0.01) and LV deformation parameters (r = −0.31, p = 0.03) in patients with STEMI and negatively correlated with ABI parameters (r = −0.39, p = 0.03, r = −0.40, p = 0.03, respectively) in patients with SIHD. MiRNA146 did not have any significant correlations, while higher values of miRNA21 were associated with lower values of GLS in STEMI patients and with higher values of GLS in SIHD patients. Both MMP1 and MMP9 correlated negatively with LVEF (r = −0.27, p = 0.04, r = −0.40, p = 0.001, respectively) and GLS in patients with STEMI, and positively with arterial stiffness in patients with SIHD (r = 0.40 and r = 0.32, respectively; both p < 0.05). MiRNA126, miRNA21, and both MMP1 and MMP9 are associated with LV and arterial function parameters in patients with acute coronary syndrome. Meanwhile, they inversely correlate with arterial function in patients with chronic atherosclerotic disease. However, further studies are needed to establish whether these novel biomarkers have diagnosis and prognosis significance.

Identification of circulating microRNA-126-3p as a new biomarker for coronary artery calcification

Multiple Non-coding ANRIL Transcripts Are Associated with Risk of Coronary Artery Disease: a Promising Circulating Biomarker

Association Between Elevated Plasma Microrna-223 Content and Severity of Coronary Heart Disease

MicroRNA-32 Promotes Calcification in Vascular Smooth Muscle Cells: Implications As a Novel Marker for Coronary Artery Calcification.

Circulating microRNA-126 &122 in patients with coronary artery disease: Correlation with small dense LDL

Signature Of Circulating Micrornas As Potential Biomarkers In Vulnerable Coronary Artery Disease

Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results from the China-Cardiovascular Disease Study -

Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease.

Analysis of Plasma Mir-208A and Mir-370 Expression Levels for Early Diagnosis of Coronary Artery Disease

The Investigation of the Plasma Mir-126 and Mir-143 Expression in Patients with Coronary Heart Disease

Circulating miR-183-5p levels are positively associated with the presence and severity of coronary artery disease

Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells As Biomarkers for Coronary Artery Disease.

Early Detection of Coronary Artery Disease by Micro-RNA Analysis in Asymptomatic Patients Stratified by Coronary CT Angiography

Identifying Microrna Biomarkers And Constructing Microrna-Regulated Networks In Coronary Artery Diseases: A Meta-Analysis

Relationship between miR-143,miR-145 levels and severity of coronary atherosclerosis

Circulating MicroRNAs as Novel Biomarkers in Risk Assessment and Prognosis of Coronary Artery Disease

Predictive Effects of Circulating Mir-221, Mir-130A and Mir-155 for Coronary Heart Disease: A Multi-Ethnic Study in China

Diagnostic and Prognostic Role of Circulating microRNAs in Patients with Coronary Artery Disease-Impact on Left Ventricle and Arterial Function

Circulating miR‐133a‐3p and miR‐451a as potential biomarkers for diagnosis of coronary artery disease

Diagnostic and Prognostic Role of Circulating microRNAs in Patients with Coronary Artery Disease—Impact on Left Ventricle and Arterial Function

Identification of miR136, miR155, and miR183 in vascular calcification in human peripheral arteries